ACCELERON PHARMA INC. Investing Cash Flow
ACCELERON PHARMA INC. reported Investing Cash Flow of -$131.56 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2021-11-04
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for the quarter ending 2021-09-30 was $56.79M.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for the quarter ending 2021-06-30 was -$37.13M, a 224.01% decline year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for the quarter ending 2021-03-31 was -$151.21M, a 295.16% decline year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for the quarter ending 2020-12-31 was -$29.60M, a 136.22% decline year-over-year.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for fiscal 2020 was $25.60M.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for fiscal 2019 was -$71.29M, a 157.99% decline from fiscal 2018.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for fiscal 2018 was $122.93M.
- ACCELERON PHARMA INC. net cash provided by (used in) investing activities for fiscal 2017 was -$64.37M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $56.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $19.66M derived: sum of 2 quarters · filed 2021-11-04 | -$131.56M 10-Q · filed 2021-11-04 | -$161.16M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | -$37.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$188.35M 10-Q · filed 2021-08-05 | -$217.95M derived: sum of 3 quarters · filed 2021-08-05 | -$270.18M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | -$151.21M 10-Q · filed 2021-05-06 | -$180.81M derived: sum of 2 quarters · filed 2021-05-06 | -$233.04M derived: sum of 3 quarters · filed 2021-11-04 | -$203.10M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | -$29.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$81.83M derived: sum of 2 quarters · filed 2021-11-04 | -$51.88M derived: sum of 3 quarters · filed 2021-11-04 | $25.60M 10-K · filed 2021-02-25 |
| 2020-09-30 | -$52.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$22.29M derived: sum of 2 quarters · filed 2021-11-04 | $55.20M 10-Q · filed 2021-11-04 | $136.91M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $29.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $107.43M 10-Q · filed 2021-08-05 | $189.14M derived: sum of 3 quarters · filed 2021-08-05 | $227.12M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $77.48M 10-Q · filed 2021-05-06 | $159.19M derived: sum of 2 quarters · filed 2021-05-06 | $197.18M derived: sum of 3 quarters · filed 2021-05-06 | $158.76M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $81.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $119.69M derived: sum of 2 quarters · filed 2021-02-25 | $81.28M derived: sum of 3 quarters · filed 2021-02-25 | -$71.29M 10-K · filed 2021-02-25 |
| 2019-09-30 | $37.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$434.00K derived: sum of 2 quarters · filed 2020-11-05 | -$153.00M 10-Q · filed 2020-11-05 | -$93.24M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$38.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$190.99M 10-Q · filed 2020-08-06 | -$131.22M derived: sum of 3 quarters · filed 2021-02-25 | -$86.12M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$152.57M 10-Q · filed 2020-05-11 | -$92.80M derived: sum of 2 quarters · filed 2021-02-25 | -$47.70M derived: sum of 3 quarters · filed 2021-02-25 | -$17.72M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $59.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $104.87M derived: sum of 2 quarters · filed 2021-02-25 | $134.85M derived: sum of 3 quarters · filed 2021-02-25 | $122.93M 10-K · filed 2021-02-25 |
| 2018-09-30 | $45.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $75.08M derived: sum of 2 quarters · filed 2019-11-06 | $63.16M 10-Q · filed 2019-11-06 | -$83.32M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $29.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $18.06M 10-Q · filed 2019-08-05 | -$128.42M derived: sum of 3 quarters · filed 2020-02-27 | -$93.42M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$11.92M 10-Q · filed 2019-05-09 | -$158.40M derived: sum of 2 quarters · filed 2020-02-27 | -$123.41M derived: sum of 3 quarters · filed 2020-02-27 | -$108.92M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$146.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$111.48M derived: sum of 2 quarters · filed 2020-02-27 | -$97.00M derived: sum of 3 quarters · filed 2020-02-27 | -$64.37M 10-K · filed 2020-02-27 |
| 2017-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $49.48M derived: sum of 2 quarters · filed 2018-10-30 | $82.12M 10-Q · filed 2018-10-30 | $87.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $14.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $47.12M 10-Q · filed 2018-08-02 | $52.00M derived: sum of 3 quarters · filed 2019-02-27 | $56.49M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $32.63M 10-Q · filed 2018-05-08 | $37.52M derived: sum of 2 quarters · filed 2019-02-27 | $42.01M derived: sum of 3 quarters · filed 2019-02-27 | $30.75M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $9.38M derived: sum of 2 quarters · filed 2019-02-27 | -$1.89M derived: sum of 3 quarters · filed 2019-02-27 | -$108.81M 10-K · filed 2019-02-27 |
| 2016-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$6.77M derived: sum of 2 quarters · filed 2017-11-07 | -$113.69M 10-Q · filed 2017-11-07 | -$117.81M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$11.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$118.18M 10-Q · filed 2017-08-03 | -$122.30M derived: sum of 3 quarters · filed 2018-02-27 | -$109.18M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$106.92M 10-Q · filed 2017-05-08 | -$111.04M derived: sum of 2 quarters · filed 2018-02-27 | -$97.92M derived: sum of 3 quarters · filed 2018-02-27 | -$91.51M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $9.00M derived: sum of 2 quarters · filed 2018-02-27 | $15.40M derived: sum of 3 quarters · filed 2018-02-27 | -$108.97M 10-K · filed 2018-02-27 |
| 2015-09-30 | $13.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $19.52M derived: sum of 2 quarters · filed 2016-11-03 | -$104.85M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $6.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$117.97M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$124.37M 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | -$514.00K 10-K · filed 2017-03-01 | |||
| 2013-12-31 | -$307.00K 10-K · filed 2016-02-25 |